跳至主要内容
临床试验/NCT04347200
NCT04347200招募中不适用

Registry Dedicated to Assess the Risk of Ischemic and Hemorrhagic Complications of Long-term Antithrombotic Therapy in Patients With Chronic Coronary Syndromes

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation2 个研究点 分布在 2 个国家目标入组 2,000 人开始时间: 2015年1月15日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
2,000
试验地点
2
主要终点
composite of major adverse cardiovascular events (MACE)

研究概览

简要总结

To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with chronic coronary syndromes

详细描述

The register is a Russian prospective single-center observational study of patients who have indications for long-term antithrombotic therapy in connection with chronic coronary syndromes

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • coronary artery disease , confirmed by history of myocardial infarction, or revascularization, or definitive evidence of CAD on imaging

排除标准

  • Subjects who are unwilling or unable to provide informed consent.
  • Acute coronary syndrome within 12 months before inclusion
  • Severe chronic heart failure (NYHA IV)
  • Stroke within 6 months before inclusion
  • Severe liver or muscle disease
  • Severe kidney disease / renal failure with creatinine > 3 mg/dl
  • Conceivable impossibility to come in touch with the patient or his family at 1-year after the intervention -

结局指标

主要结局

composite of major adverse cardiovascular events (MACE)

时间窗: inclusion up to 5 years

stroke, myocardial infarction, stent thrombosis \[definite or probable\], or urgent revascularization, cardiac death

composite of any bleeding events

时间窗: inclusion up to 5 years

major, clinically relevant nonmajor, minor (BARC, ISTH)

次要结局

  • Severity of peripheral atherosclerosis(inclusion)
  • Mutations in following genes(inclusion)

研究者

发起方
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
申办方类型
Other Gov
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验